Fernando Herranz: "Breaking the bonds: Nano-enabled radiopharmaceuticals for cancer imaging and therapy"
Fernando Herranz gave this lecture on the 30th of June of 2025, hosted by Juan Pellico from the Nanoparticles and Nanocomposites (NN) Group. Watch the video here.
Abstract
Radiopharmaceuticals are revolutionizing cancer diagnosis and therapy by enabling targeted delivery of radioactive isotopes. However, conventional chelator-based chemistry used to bind radionuclides to biomolecules presents significant limitations, including instability, off-target effects, and restricted versatility.
Nanomaterials offer a transformative alternative, providing robust platforms for radiolabeling without traditional chelators. Their tunable properties enable enhanced targeting, controlled release, and multimodal imaging capabilities. This talk explores how nanotechnology is reshaping the landscape of nuclear medicine, overcoming existing barriers, and unlocking new possibilities for precision oncology—from improved imaging agents to next-generation theranostics.
